Skip to main content
SpringerLink
Log in

Efficacy of Branched-Chain Amino Acids in the Treatment of Hepatic Encephalopathy

  • Chapter
Hepatic Encephalopathy in Chronic Liver Failure

Abstract

All therapy in patients with liver disease is a play for time, until the well-known regenerative capacity of the liver can occur. The regenerative capacity of the liver is an extremely complicated process, involving a series of permissive and stimulatory factors, such as steroids, triiodothyronine, insulin and glucagon and other factors, such as the ileal factor, which remain unknown. Of all the factors that are currently known which influence liver regeneration, nutrition is the easiest one for the physician to manipulate. Nutrition in the therapy of patients with liver disease has long been important in hepatology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. J. E. Fischer, J. M. Funovics, A. Aguirre, J. H. James, J. M. Keane, R. I. C. Wesdorp, N. Yoshimura,and T. Westman, The role of plasma amino acids in hepatic encephalopathy, Surgery 78: 276 (1975).

    CAS  Google Scholar 

  2. J. Wahren, P. Felig, and L. Hagenfeldt, Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus, J. Clin. Invest. 57: 987 (1976).

    CAS  Google Scholar 

  3. A. L. Goldberg, Mechanism of growth and atrophy of skeletal muscle in “Muscle Biology”, New York, Dekker, vol. I, pp. 89–118 (1972).

    Google Scholar 

  4. T. Pozedsky, P. Felip, J. S. Soeldner, and G. F. Cahill, Jr., Insulin blockage of amino acid release by human forearm tissues, Trans. Assoc. Am. Physicians 81: 258 (1968).

    Google Scholar 

  5. H. N. Munro, J.G. Black,and W. S. T. Thomson, The mode of action of dietary carbohydrate on protein metabolism, Brit. J. Nutr. 13: 475 (1959).

    CAS  Google Scholar 

  6. R. Oddessey and A. L. Goldberg, Oxidation of leucine by rat skeletal muscle, Amer. J. Phys. 223: 1376 (1972).

    Google Scholar 

  7. R. S. Sherwin, Effect of starvation on the turnover and metabolic response to leucine, J. Clin. Invest. 21: 1471 (1978).

    Google Scholar 

  8. H. R. Freund, H. J. James, and J. E. Fischer, Nitrogen sparing mechanisms of singly administered branched-chain amino acids in the injured rat, Surgery 90: 237 (1981).

    PubMed  CAS  Google Scholar 

  9. A. Sakamoto, L. L. Moldawer, A. Bothe, B. R. Bistrian, and G. L. Blackburn, Are the nitrogen sparing mechanisms of branched-chain amino acid administration really unique? Surg. Forum 31: 99 (1980).

    CAS  Google Scholar 

  10. R. A. Gelfaud, R. G. Hendler, and R. S. Sherwin, Dietary carbohydrate and metabolism of ingested protein, Lancet i: 65 (1979).

    Article  Google Scholar 

  11. J. H. James, P. M. Herlin, L. Edwards, C. A. Nachbauer, and J. E. Fischer, Effect of infusion of branched-chain amino acids on concentrations of amino acids in plasma and brain and on brain catecholamines after total hepatectomy in the rat, Life Sciences 30: 1361 (1982).

    Article  PubMed  CAS  Google Scholar 

  12. J. E. Fischer and R. J. Baldessarini, Pathogenesis and therapy of hepatic coma, in: “Progress in Liver Disease” H. Popper and F. Schaffner, eds., Grune and Stratton, New York, pp. 363–397 (1976).

    Google Scholar 

  13. A. Okada, S. Kamata, C. W. Kim, and Y. Kawashima, Treatment of hepatic encephalopathy with BCAA-rich amino acid mixture, in: “Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids,” M. Walser, R. Williamson, eds., Elsevier North Holland, New York, pp. 447–452 (1981).

    Google Scholar 

  14. L. Capocaccia, V. Calcaterra, C. Cangiano, A. Cascino, F. Fiaccadori, S. Gentile, F. Ghinelli, G. Pelosi, O. Riggio, F. Rossi-Fanelli, D. Sacchini, and G. Giunchi, Therapeutic effect of branched-chain amino acids in hepatic encephalopathy: A preliminary study, in: “Medical and Surgical Problems of Portal Hypertension,” Orloff, M. J., Stipa, S., Ziparo, V. eds., Academic Press, London, New York, pp. 239–249 (1979).

    Google Scholar 

  15. H. Freund, J. Dienstag, F. Lehrich, N. Yoshimura, R. R. Bradford, H. Rosen, S. Atamian, E. Slemmer, J. Holroyde, and J. E. Fischer, Infusion of BCAA solution in patients with hepatic encephalopathy, Ann. Surg. 196: 209 (1982).

    Article  PubMed  CAS  Google Scholar 

  16. D. B. Silk, M. A. Hanid, and P. N. Trewby, Treatment of fulminant hepatic failure by polyacrylonitrile membrane haemodialysis, Lancet ii: 1 (1977).

    Article  Google Scholar 

  17. B. G. Gazzard, M. J. Weston, J. M. Murray-Lyon, H. Flax, C. O. Record, R. Williams, B. Portmann, P. G. Langley, E. H. Dunlop, P. J. Mellon, and M. B. Ward, Charcoal hemoperfusion in the treatment of fulminant hepatic failure, Lancet i: 1301 (1974).

    Article  Google Scholar 

  18. S. Rakette, M. Fischer, H. J. Reimann, and S. V. Sommoggy, Effects of a special amino acid solution in patients with liver cirrhosis and hepatic encephalopathy, in: “Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids” M. Walser, R. Williamson eds., Elsevier, North-Holland, New York, pp. 419–427 (1981).

    Google Scholar 

  19. T. Higashi, A. Watanabe, S. Hayashi, T. Obata, N. Tanei, and H. Nagashima, Effect of branched-chain amino acid infusion on alterations in CSF neutral amino acids and their transport across the blood brain barrier in hepatic encephalopathy, in: “Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids,” M. Walser, R. Williamson eds., Elsevier, North-Holland, New York, pp. 465–470 (1981).

    Google Scholar 

  20. E. Holm, J. P. Streibel, P. Moller, and M. Hartman, Amino acid solutions for parenteral nutrition and for adjuvant treatment of encephalopathy in liver cirrhosis, studies concerning 120 patients, in: “Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids,” M. Walser, R. Williamson eds., Elsevier, North-Holland, New York, pp. 513–518 (1981).

    Google Scholar 

  21. F. Rossi Fanelli, O. Riggio, C. Cangiano, A. Cascino, D. De Conciliis, M. Merli, M. Stortoni, and G. Giunchi, Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study, Dig. Dis. Sci. 27: 929 (1982).

    Article  PubMed  CAS  Google Scholar 

  22. F. Fiaccadori, F. Ghinelli, G. Pedretti, G. Pelosi, D. Sacchini, M. L. Zeneroli, E. Rossi, P. Gibertini, and E. Ventura, Branched-chain amino acid enriched solutions in hepatic encephalopathy, a controlled trial (submitted for publication).

    Article  Google Scholar 

  23. F. B. Cerra, N. K. Cheung, J. E. Fischer, N. Kaplowitz, E. R. Schiff, J. L. Deinstag, C. D. Mabry, C. M. Leevy, and T. Kiernan, A multicenter trial of branched-chain enriched amino acid infusion (F080) in hepatic encephalopathy (HE), Hepatology 2: (5) 699 (1982).

    Google Scholar 

  24. R. M. Abel, C. H. Beck, Jr., W. M. Abbott, J. A. Ryan, G. O. Barnett, and J. E. Fischer, Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose, N. Engl. J. Med. 288: 695 (1973).

    Article  PubMed  CAS  Google Scholar 

  25. J. W. Alexander, B. G. McMillan, J. D. Stinnett, C. K. Ogle, R. C. Bozían, J. E. Fischer, J. B. Oakes, M. J. Morris, and R. Krummel, Beneficial effects of aggressive protein feeding in severely burned children, Ann. Surg. 192: 505 (1980).

    CAS  Google Scholar 

  26. E. Strauss, W. R. Santos, and E. C. DaSilva, A randomized controlled clinical trial for the evaluation of the efficacy of balanced amino acid solution compared to neomycin in hepatic encephalopathy (submitted for publication).

    Google Scholar 

  27. G. Polier-Layrargues, O. Duhamel, G. Cuilleret, P. Bovics, H. Bellet-Hermann, and H. Michel, Treatment of hepatic encephalopathy by infusions of a modified amino acid solution. Results of a controlled study in 33 cirrhotic patients (submitted for publication).

    Google Scholar 

  28. J. J. Wahren, J. Denis, P. Desurmont, L. S. Erikson, J. M. Escoffier, A. P. Gauthier, L. Hagenfeldt, H. Michel, P. Opolon, J. Paris, and M. Veyrac, Is i.v. administration of branched-chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study, Europ. Soc. Parent. Enter. Nutr. FC47: 61 (1981).

    Google Scholar 

  29. A. Cascino, C. Cangiano, V. Calcaterra, F. Rossi-Fanelli, and L. Capocaccia, Plasma amino acid imbalance in patients with liver disease, Am. J. Dig. Dis. 23: 591 (1978).

    CAS  Google Scholar 

  30. F. Rossi-Fanelli, F. H. Freund, R. Krause, A. R. Smith, J. H. James, S. Castorina-Ziparo, and J. E. Fischer, Induction of coma in normal dogs by infusion of aromatic amino acids and prevention by addition of branched chain amino acids, Gastroenterology 83: 664 (1982).

    PubMed  CAS  Google Scholar 

  31. C. Cangiano, F. Rossi-Fanelli, and L. Capocaccia, Personal communication.

    Google Scholar 

  32. H. Freund, N. Yoshimura, and J. E. Fischer, Chronic hepatic encephalopathy. Long-term therapy with a branched-chainamino-acid-enriched elemental diet, JAMA 242: 347 (1979).

    Article  PubMed  CAS  Google Scholar 

  33. D. Horst, N. Grace, H. O. Conn, E. Schiff, S. Schenker, A. Viteri, D. Law, and C. E. Atterbury, A double-blind randomized comparison of dietary protein and an oral branched chain amino acid (BCAA) supplement in cirrhotic patients with chronic portal-systemic encephalopathy (PSE) (ABS), Hepatology 5: 518 (1981).

    Google Scholar 

  34. E. M. Egberts, W. Hampter, and P. Jurgens, Effective treatment of latent portosystemic encephalopathy (PSE) with oral branched chain amino acids (BCAA). Presented at AISF Conference on Hepatic Coma, Rome, November 19–20, 1982 (this volume).

    Google Scholar 

  35. L. S. Eriksson, A. Persson, and J. Wahren, Branched chain amino acids in the treatment of chronic hepatic encephalopathy, Gut 23: 801 (1982).

    Article  PubMed  CAS  Google Scholar 

  36. H. Schomerus, In discussion of paper 39, AISF Conference on Hepatic Coma, Rome, November 19–20, 1982 (this volume).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, USA

    J. E. Fischer

Authors
  1. J. E. Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Rome, Rome, Italy

    Livio Capocaccia  & Filippo Rossi-Fanelli  & 

  2. Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, USA

    Joseph E. Fischer

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Fischer, J.E. (1984). Efficacy of Branched-Chain Amino Acids in the Treatment of Hepatic Encephalopathy. In: Capocaccia, L., Fischer, J.E., Rossi-Fanelli, F. (eds) Hepatic Encephalopathy in Chronic Liver Failure. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4787-3_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4787-3_32

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4789-7

  • Online ISBN: 978-1-4684-4787-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation